Skip to main content
SpringerLink
Log in

Administering eszopiclone at bedtime to patients with depression and insomnia who are being treated with fluoxetine improves their QOL

  • Clinical study
  • Published:
PharmacoEconomics & Outcomes News

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

REFERENCE

  1. McCall WV, D'Agostino RB, Kimball JN, Boggs N, Lasater B, Dunn A, Haskett RF, McDonald WM, Krystal A, Rosenquist PB.Eszopiclone at bedtime improves the quality of life in depressed insomniacs receiving fluoxetine. 23rd Annual Meeting of the Associated Professional Sleep Societies: 348-349 abstr. 1068, 6 Jun 2009. Available from: URL: http://www.apss.org/

Download references

Rights and permissions

Reprints and permissions

About this article

Cite this article

Administering eszopiclone at bedtime to patients with depression and insomnia who are being treated with fluoxetine improves their QOL. Pharmacoecon. Outcomes News 581, 10 (2009). https://doi.org/10.2165/00151234-200905810-00030

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00151234-200905810-00030

Keywords

Search

Navigation